Clinical Trial Update: A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD) [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetics and safety study evaluated fostemsavir (BMS-663068) in subjects with normal renal function and varying degrees of renal impairment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fostemsavir (fostemsavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED